A Study To Test The Medicine Loha Guugulu (Medicated herbo mineral tablet) Works In Lowering Medovriddi (High Cholestrol And Fat levels in the blood )

An Interventional Study To Evaluate The Effect Of Loha Guggulu On Lipid Profile In Medovriddi - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/02/081438

Enrollment

Registered

2025-02-28

Start date

Unknown

Completion date

Unknown

Last updated

2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E785- Hyperlipidemia, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients who fulfil daignostic criteria 2. Patient of age between 18 years to 60 years were selected 3. Patients having BMI between 25-35kg/m2 4. Patients willing to participate in the study and ready to sign informed consent form

Exclusion criteria

Exclusion criteria: 1. Patients having major illnesses like Diabetes mellitus Hypertension Cardiac Problems Thyroid disorders 2. Drug induced Hyperlipidaemia 3. Pregnant and lactating females

Design outcomes

Primary

Measure	Time frame
To evaluate the effect of loha guggulu on lipid profile in medovriddi conditionTimepoint: 30 days of treatment. Follow up on 45th day.	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDr Lakshmi

Alvas Ayurveda Medical College and Hospital

drknraamc@gmail.com9481511292

Outcome results